The above-mentioned opinion refers to a number of EFSA assessments (EFSA AFC Panel 2008, EFSA NDA Panel, 2008a; 2008b; 2008c, EFSA ANS Panel 2017) concerning lycopene exposure when used as a novel food or a food additive. It is concluded from those assessments that the overall exposure to lycopene when all possible sources are taken into account, namely from background diet, novel food and food additive use, may exceed the established ADI.